Abstract
This study evaluated the added significance of nm23-H1 to that of E-cadherin in determining metastatic proclivity in primary sporadic colorectal carcinomas (SCRCs). A clinical cohort of 52 SCRCs was examined for the significance of nm23-H1 and E-cadherin mRNA levels and E-cadherin protein expression levels into the progression of colorectal tumor invasion, determined by their relevance compared with conventional biological markers. A more than twofold decreased expression of nm23-H1 mRNA was reported in 28/52 (54%) of the carcinomas and was positively associated with the presence of nodal metastases and Astler-Coller stages B1 and B2 in 29% and 35% of the SCRCs, respectively. Reduced expression of E-cadherin mRNA was reported in 38.5% of the carcinomas and was similarly associated with stages Astler-Coller B1 and B2 in 27% of the SCRCs. Decreased E-cadherin immunohistochemical expression (grades II and III) was observed in 67% of the samples. E-cadherin mRNA and protein expression were significantly related to each other. The nm23-H1 (+)/E-cadherin (+) coexpression profile was observed in 31% and was significantly related to the absence of lymph node metastases in 31% and stages Astler-Coller B1 and B2 in 29% of the carcinomas examined. Furthermore, the nm23-H1 (−)/E-cadherin (+) coexpression profile was coupled to decreased E-cadherin immunohistochemical protein detection (grade II) in 21% of the cases examined. These findings suggest that impairment of nm23-H1 expression is an early event into the progression of colorectal metastasis that precedes E-cadherin transcriptional silencing in the majority of SCRCs examined. Nm23-H1 may therefore play an important role in suppressing the early steps of metastasis in sporadic cases of colorectal carcinomas.
Similar content being viewed by others
Abbreviations
- Ab :
-
Antibody
- IHC :
-
Immunohistochemistry
- PCR :
-
Polymerase chain reaction
- RT :
-
Reverse transcription
- SCRC :
-
Sporadic colorectal carcinoma
References
Killion JJ, Fdler IJ (1989) The biology of tumor metastasis. Semin Oncol 16:105–115
Kohn EC, Liotta L (1993) Invasion and metastasis: new approaches to an old problem. Oncology 7:47–62
Strackle ML, Liotta LA (1995) Molecular mechanism of tumor cell metastasis. In: Mendelsohn J, Howley P, Israel A, Liotta LA (eds) The molecular basis of cancer–. Saunders, Philadelphia, pp 223–247
Steeg PS, Bevilacqua G, Kopper L, Thogeirsson UP, Talmadge JE, Liotta LA, Sobel ME (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80:200–204
Varesco L. Caligon MA, Simi P, Black DM, Nardimi V, Casarino L, Rocchi M, Ferrara G, Solomon E, Bevilacqua G (1992) The nm23 gene maps to human chromosome band 17q22 ans shows a restriction fragment length polymorphism with BglII. Genes Chromosomes Cancer 4:84–88
Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii N, Kimura N, Nagataki S (1992) Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 84:1349–1354
Yamaguchi A, Urano T, Goi T, Takeuchi K, Niimoto S, Nakagawara G, Furukawa K, Shiku H (1994) Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer 73:2280–2284
Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB (1993) Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst 85:727–731
Kodera Y, Isobe K, Yamauchi M, Kondoh K, Kimura N, Akiyama S, Itoh K, Nakashima I, Takagi H (1994) Expression of nm23 H-1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis. Cancer 73:259–265
Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H (1993) Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer 55:66–71
Ayhan A, Yasui W, Yokozaki H, Kitadai Y, Tahara E (1993) Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas. Virchows Arch B Cell Pathol 63:213–218
Tannapfel A, Kockerling F, Katalinic A, Wittekind C (1995) Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum 38:651–654
Haut M, Steeg PS, Willson JK, Markowitz SD (1991) Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 83:712–716
Heide I, Thiede C, Poppe K, de Kant E, Huhn D, Rochlitz C (1994) Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer. Br J Cancer 70:1267–1271
Myeroff LL, Markowitz SD (1993) Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of lowand high metastatic potential. J Natl Cancer Inst 85:147–152
Lee JC, Lin YJ, Chow NH, Wang ST (2001) Reappraisal of the role of NM23-H1 in colorectal cancers. J Surg Oncol 76:58–62
Takeichi M (1995) Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7:619–627
Wijnhoven BP, Pignatelli M (1999) E-cadherin-catenin: more than a "sticky" molecular complex. Lancet 354:356–357
Christofori G, Semb H (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24:73–76
Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S (1995) Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92:7416–7419
Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ (2000) E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92:569–573
Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190–193
Garinis GA, Menounos PG, Spanakis NE, Papadopoulos K, Karavitis G, Parassi I, Christeli E, Patrinos GP, Manolis EN, Peros G (2002) Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J Pathol 198:442–449
Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S (1994) E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci U S A 91:1858–1862
Ilyas M, Tomlinson IP, Hanby A, Talbot IC, Bodmer WF (1997) Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut 40:654–659
Wheeler JM, Kim HC, Efstathiou JA, Ilyas M, Mortensen NJ, Bodmer WF (2001) Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 48:367–371
Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne K, Clark G, Steeg P (2001) Elevation of breast carcinoma nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res 61:2320–2327
Heimann R, Lan F, McBride R, Hellman S (2000) Separating favourable from unfavourable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res 60:298–304
Palacios F, Schweitzer JK, Boshans RL, D'Souza-Schorey C (2002) ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol 4:929–936
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garinis, G.A., Manolis, E.N., Spanakis, N.E. et al. High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas. J Mol Med 81, 256–263 (2003). https://doi.org/10.1007/s00109-003-0420-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-003-0420-4